First Wave BioPharma Dividend
Dividend criteria checks 0/6
First Wave BioPharma does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$7.95 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
First Wave BioPharma announces pricing of $6.0 million public offering
Oct 07First Wave BioPharma extends selloff after announcing strategic shift
Sep 19First Wave stock slips ~21% on plans for amended FDA application for enzyme adrulipase
Sep 07First Wave BioPharma announces 1-for-30 reverse stock split
Aug 25First Wave BioPharma to raise capital in convertible preferred stocks offering
Jul 15First Wave BioPharma Set For New Growth Trajectory With GI Pipeline Expansion De-Risking The Investment
Oct 19AzurRx Biopharma doses first patient in mid-stage niclosamide COVID-19 study
Jun 07AzurRx BioPharma: An Assessment
May 02AzurRx Officially A COVID-19 Play - The Right Dose For Your Portfolio
Jan 31AzurRx BioPharma, First Wave Bio in niclosamide licensing pact for gastrointestinal infections
Jan 04AzurRx up 9% on advancement of mid-stage study of MS1819 in CF patients
Nov 30Is AzurRx BioPharma (NASDAQ:AZRX) In A Good Position To Invest In Growth?
Nov 19Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if FWBI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if FWBI's dividend payments have been increasing.
Dividend Yield vs Market
First Wave BioPharma Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (FWBI) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (FWBI) | n/a |
Notable Dividend: Unable to evaluate FWBI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate FWBI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate FWBI's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as FWBI has not reported any payouts.